Intercept Pharmaceuticals, Inc.

VANGUARD GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

12/18/2023

Shares

2,071,232

Value ($000)

38,401

Weight

0.0%

2013 Q4 - 2023 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	12/18/2023	38,401	0.0%	2,071,232	9/30/2023
2023 Q2	8/14/2023	51,914	0.0%	4,693,817	6/30/2023
2023 Q1	7/14/2023	52,859	0.0%	3,935,919	3/31/2023
2022 Q4	2/10/2023	45,001	0.0%	3,637,935	12/31/2022
2022 Q3	11/14/2022	37,755	0.0%	2,706,414	9/30/2022
2022 Q2	8/12/2022	34,652	0.0%	2,509,159	6/30/2022
2022 Q1	5/13/2022	38,873	0.0%	2,389,249	3/31/2022
2021 Q4	2/14/2022	32,120	0.0%	1,971,759	12/31/2021
2021 Q3	11/12/2021	42,030	0.0%	2,830,263	9/30/2021
2021 Q2	8/13/2021	67,363	0.0%	3,373,212	6/30/2021
2021 Q1	5/14/2021	76,074	0.0%	3,296,117	3/31/2021
2020 Q4	2/12/2021	69,875	0.0%	2,828,955	12/31/2020
2020 Q3	11/16/2020	113,593	0.0%	2,739,825	9/30/2020
2020 Q2	8/14/2020	119,067	0.0%	2,485,217	6/30/2020
2020 Q1	5/15/2020	147,639	0.0%	2,344,972	3/31/2020
2019 Q4	2/14/2020	284,574	0.0%	2,296,438	12/31/2019
2014 Q2	8/11/2014	153,826	0.0%	650,073	6/30/2014
2014 Q1	5/13/2014	191,509	0.0%	580,699	3/31/2014
2013 Q4	2/12/2014	18,052	0.0%	264,381	12/31/2013